?Efficacy of prebiotic products on admitted patients with Covid-19
Phase 3
Recruiting
- Conditions
- covid 19.COVID-19, virus identifiedU07.1
- Registration Number
- IRCT20161206031255N4
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Informed consent
positive PCR or positive CT-scan
Exclusion Criteria
Patient's unwillingness to participate
Dialysis patients
ICU admitted or intubated patients
Pregnancy orbreast feeding
use of steroid or immunosupressive medicatns
use of the other herbal medications
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cough. Timepoint: Daily. Method of measurement: By question from the patient.;Breath rate. Timepoint: Four times in a day. Method of measurement: physical exam.;Fever. Timepoint: Four times in a day. Method of measurement: physical exam.;Weakness. Timepoint: daily. Method of measurement: examination.;Myalgia. Timepoint: daily. Method of measurement: history.;C reactive protein. Timepoint: Daily. Method of measurement: Blood lab.;Lymphocyte. Timepoint: Daily. Method of measurement: Blood lab.;Blood Oxygen saturation. Timepoint: four times in a day. Method of measurement: physical examination.;Diarrhea. Timepoint: daily. Method of measurement: Ask from patient.
- Secondary Outcome Measures
Name Time Method